Majewski's polydactyly syndrome
(Redirected from Short rib-polydactyly syndrome type 2)
Majewski's polydactyly syndrome is a rare genetic disorder characterized by the presence of extra fingers or toes (polydactyly), along with other physical abnormalities. This condition is named after the Polish geneticist Friedrich Majewski, who first described it.
Clinical Features[edit | edit source]
Individuals with Majewski's polydactyly syndrome typically exhibit the following clinical features:
- Polydactyly: Extra digits on the hands and/or feet.
- Syndactyly: Fusion of fingers or toes.
- Short stature: Below-average height for age and sex.
- Microcephaly: Smaller than normal head size.
- Craniofacial abnormalities: These may include a prominent forehead, a broad nasal bridge, and a small jaw (micrognathia).
Genetics[edit | edit source]
Majewski's polydactyly syndrome is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific gene or genes involved in this syndrome have not been definitively identified.
Diagnosis[edit | edit source]
Diagnosis of Majewski's polydactyly syndrome is primarily based on clinical evaluation and the identification of characteristic physical features. Genetic testing may be used to confirm the diagnosis and to identify carriers of the gene mutation.
Management[edit | edit source]
There is no cure for Majewski's polydactyly syndrome. Management of the condition focuses on addressing the symptoms and may include:
- Surgical correction of polydactyly and syndactyly.
- Supportive therapies for developmental delays and other associated conditions.
- Regular monitoring and medical care to manage any complications.
Prognosis[edit | edit source]
The prognosis for individuals with Majewski's polydactyly syndrome varies depending on the severity of the symptoms and the presence of any associated conditions. Early intervention and supportive care can improve the quality of life for affected individuals.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD